Home › Stocks › DRMA › Changes

Who bought & sold DRMA (Q3 2026)

Funds holding (Q3 2026)15
New positions7
Added2
Reduced3
Exited5

As of Q3 2026, 15 institutional funds reported holding DRMA (DERMATA THERAPEUTICS INC): 7 opened new positions, 2 added, 3 trimmed and 5 exited entirely. 13F filings are quarter-end snapshots of positioning, not intra-quarter trades.

New positions (7)

Fund Shares Value Weight
Citadel Advisors New 32.80K $36.08K —
HRT FINANCIAL LP New 19.40K $21.00K —
STATE STREET CORP New 18.75K $20.62K —
JANE STREET GROUP, LLC New 16.59K $18.25K —
Citigroup Inc New 6.62K $7.29K —
VANGUARD CAPITAL MANAGEMENT LLC New 5.44K $5.98K —
JPMorgan Chase & Co New 3 $3 —

Added to positions (2)

Fund Shares Value Weight Change
UBS Group AG 17.11K $18.83K — +319 sh (+1.9%)
SBI Securities Co., Ltd. 102 $112 — +1 sh (+1.0%)

Reduced positions (3)

Fund Shares Value Weight Change
Tower Research Capital LLC (TRC) 313 $344 — -3.55K sh (-91.9%)
XTX Topco Ltd 12.88K $14.16K — -1.91K sh (-12.9%)
Geode Capital Management 20.10K $22.11K — -102 sh (-0.5%)

Exited positions (5)

Held in the prior quarter but not reported in the latest filing.

Fund Shares Value Weight
GEODE CAPITAL MANAGEMENT, LLC Exited 20.20K $26.06K —
SUSQUEHANNA INTERNATIONAL GROUP, LLP Exited 15.99K $20.63K —
Advisory Alpha, LLC Exited 10.00K $12.90K —
MCF Advisors LLC Exited 1.73K $2.23K —
BARCLAYS PLC Exited 270 $348 —